Medicare has negotiated steep new prices for 15 high-cost drugs, including Novo Nordisk’s blockbuster semaglutide (Wegovy and Ozempic), with negotiated prices set to take effect in 2027.The move cuts projected Medicare spending by an estimated $8.5 billion to $12 billion annually and forces drugmakers to reassess pricing, access, and strategy…
Bitcoin ripped back above $90,000 in US afternoon trading, a surprise reversal that defied the historical weak Wednesdays before…
Gold prices are forecast to rise to $4,900 per ounce next year, according to Daan Struyven, head of oil…
Germany is moving into December with a slight lift in consumer sentiment as households prepare for the holiday season.…
Puma shares rallied more than 13% on Thursday after reports that Chinese sportswear giant Anta Sports is weighing a…
Italian lawmakers are pushing ahead with a controversial claim that the central bank’s $300 billion in gold reserves should…
The White House claims that Trump’s “America First” policies are bringing in trillions of dollars in new investments into…
Severe floods in Thailand’s southern region are expected to slash rubber production in the world’s largest producer by up…
Europe is juggling economic strain, shifting security risks and major legal shifts this week.In London, Chancellor Rachel Reeves is…